A Proposal to Use Iterative, Small Clinical Trials to Optimize Therapeutic HIV Vaccine Immunogens to Launch Therapeutic HIV Vaccine Development

AIDS Research and Human Retroviruses - United States
doi 10.1089/aid.2014.0172
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

A Global Approach to HIV-1 Vaccine Development

Immunological Reviews
AllergyImmunology
2013English

The Influence of HIV-1 Subtype in the Response to Therapeutic Dendritic Cell Vaccine

Open AIDS Journal
EnvironmentalPublic HealthInfectious DiseasesVirologyOccupational Health
2012English

HIV Vaccine Development

Annals of Ibadan Postgraduate Medicine
2007English

P18-10. Ability of HIV Antigens-Pulsed Monocyte-Derived Dendritic Cells to Induce HIV-specific T Cell Response: Potential Use in Therapeutic Vaccine

Retrovirology
VirologyInfectious Diseases
2009English

Cross-Reactive Anti-Hiv Antibody to Guide Vaccine Epitope Development

Science-Business eXchange
2013English

How Can Improve DNA Vaccine Modalities as a Therapeutic Approach Against HIV Infections?

Journal of AIDS & Clinical Research
2015English

Phase I Clinical Trial of an Intranodally Administered mRNA Based Therapeutic Vaccine Against HIV-1 Infection

AIDS
Infectious DiseasesAllergyImmunology
2018English

Willingness to Participate in HIV Vaccine Efficacy Trials in a Population of Fishing Communities, Uganda

Retrovirology
VirologyInfectious Diseases
2012English

Sieve Analysis in HIV-1 Vaccine Efficacy Trials

Current Opinion in HIV and AIDS
VirologyOncologyInfectious DiseasesImmunologyHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy